Bristol Myers Squibb
www.bms.comBristol Myers Squibb (BMS) is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines for serious diseases including cancer, cardiovascular disease, immunology, and neuroscience. Following more than $24 billion of acquisitions in late 2023 (Karuna, Mirati, RayzeBio) and a high-stakes pipeline transition that includes navigating the upcoming Eliquis and Opdivo patent cliffs, BMS is one of the most strategically dynamic places in pharma to interview right now. Behavioral interviews at BMS are famously structured around the company's six core values (Integrity, Urgency, Accountability, Innovation, Passion, Inclusion) and almost every question starts with "Tell me about a time when..." — making thorough STAR-method preparation essential.
What we know about Bristol Myers Squibb
Take them in order, or start where you need help most.